Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-25-001809

Chief Executive Officer acquired 6,464 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virnich Daniel Chief Executive Officer 2025-11-17 Grant or award +6,464 1,799,984 D: show line 1 in the form
Loading xslF345X05/ownership.xml…